Focus Financial Network Inc. Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Focus Financial Network Inc. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,491 shares of the medical equipment provider’s stock after purchasing an additional 218 shares during the period. Focus Financial Network Inc.’s holdings in Intuitive Surgical were worth $778,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its holdings in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on ISRG shares. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $589.61 on Thursday. The stock has a market capitalization of $210.01 billion, a PE ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. The company’s fifty day moving average is $556.91 and its 200 day moving average is $516.98. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.